國立虎尾科技大學 |

Understanding Depression = Volume 1. Biomedical and Neurobiological Background /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Understanding Depression / edited by Yong-Ku Kim.
Reminder of title:	Volume 1. Biomedical and Neurobiological Background /
other author:	Kim, Yong-Ku.
Description:	XIII, 322 p. 16 illus., 14 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Psychiatry. -
Online resource:	https://doi.org/10.1007/978-981-10-6580-4
ISBN:	9789811065804

Understanding Depression = Volume 1. Biomedical and Neurobiological Background /
Understanding Depression Volume 1. Biomedical and Neurobiological Background /[electronic resource] :edited by Yong-Ku Kim. - 1st ed. 2018. - XIII, 322 p. 16 illus., 14 illus. in color.online resource.

1.Genetic and epigenetic aspects of depression -- 1-1.Highlights on pharmacogenetics and pharmacogenomics in depression -- 1-2.Imaging genetics studies on susceptibility genes for major depressive disorder: the present and the future -- 1-3.Gene-environmental interaction and role of epigenetic in depression -- 1-4.The role of microRNAs and long noncoding RNAs in depression: diagnosis and therapeutic implication -- 1-5.The role of early life stress in HPA axis and depression -- 2.Molecular-, cellular-level aspects of depression -- 2-1.Complex role of serotonin receptors in depression -- 2-2.Emerging role of glutamate receptors in pathophysiology of depression -- 2-3.New perspective on mTOR pathways: a new target of depression -- 2-4.Cellular aging in depression: the role of telomere-telomerase system -- 2-5.Differentiation and biological markers in subtype of depression -- 3.Neural circuit-level aspect of depression -- 3-1.Molecular, structural, and functional neuroimaging in depression -- 3-2.Resting-state activity in depression; a link to spatiotemporal psychopathology -- 3-3.Functional neuroimaging in depression: a tool to predict treatment outcome and response -- 3-4.Cortical-subcortical interactions in the pathophysiology of depression -- 3-5.Pathophysiology and treatment strategies for different types of depression -- 3-6.The effect of neurostimulation in depression -- 4.Multicellular system-level aspect of depression -- 4-1.Inflammation, depression and neurodegeneration: a possible cause of dementia in late life depression? -- 4-2.Gut-microbiota-brain axis and depression -- 4-3.The interactions of immune inflammation and oxidative and nitrosative stress with the kynurenine and melatonergic pathways in depression -- 4-4.Glia-neuron cross-talk in depression -- 4-5.Depression model in primate: relevance to novel drug discovery -- 5.Species-, individual-, gender-, culture-specific aspects of depression -- 5-1.Precision psychiatry: personalized clinical approach to depression -- 5-2.Gender differences in depression -- 5-3.An up-date on the epidemiology of major depressive disorder across cultures.

This book, in two volumes, focuses on contemporary issues and dilemmas in relation to depression. The aim is to equip readers with an up-to-date understanding of the clinical and neurobiological underpinnings of depression and their relation to clinical manifestations and the development of more effective treatments. This first volume is devoted specifically to biomedical and neurobiological issues. Detailed information is presented on a wide range of topics, including genetics, molecular and cellular biology, and aspects at the neural circuit and multicellular system levels. Readers will gain a deeper appreciation of the factors and interactions underlying individual variation in responsiveness to stress and vulnerability to depression, as well as a clear understanding of potential treatment targets and causes of treatment resistance based on the latest research. A concluding section considers progress towards precision psychiatry and gender and cultural differences in depression. The companion volume is dedicated to clinical and management issues in depression. Understanding Depression will be an excellent source of information for both researchers and practitioners in the field.

ISBN: 9789811065804

Standard No.: 10.1007/978-981-10-6580-4doiSubjects--Topical Terms:

585488
Psychiatry.

LC Class. No.: RC434.2-574

Dewey Class. No.: 616.89

Understanding Depression = Volume 1. Biomedical and Neurobiological Background /
LDR:04684nam a22003975i 4500 001 997367
003 DE-He213
005 20200704174159.0
007 cr nn 008mamaa
008 201225s2018 si | s |||| 0|eng d
020 $a 9789811065804 $9 978-981-10-6580-4
024 7 $a 10.1007/978-981-10-6580-4 $2 doi
035 $a 978-981-10-6580-4
050 4 $a RC434.2-574
072 7 $a MMH $2 bicssc
072 7 $a MED105000 $2 bisacsh
072 7 $a MKL $2 thema
082 0 4 $a 616.89 $2 23
245 1 0 $a Understanding Depression $h [electronic resource] : $b Volume 1. Biomedical and Neurobiological Background / $c edited by Yong-Ku Kim.
250 $a 1st ed. 2018.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a XIII, 322 p. 16 illus., 14 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1.Genetic and epigenetic aspects of depression -- 1-1.Highlights on pharmacogenetics and pharmacogenomics in depression -- 1-2.Imaging genetics studies on susceptibility genes for major depressive disorder: the present and the future -- 1-3.Gene-environmental interaction and role of epigenetic in depression -- 1-4.The role of microRNAs and long noncoding RNAs in depression: diagnosis and therapeutic implication -- 1-5.The role of early life stress in HPA axis and depression -- 2.Molecular-, cellular-level aspects of depression -- 2-1.Complex role of serotonin receptors in depression -- 2-2.Emerging role of glutamate receptors in pathophysiology of depression -- 2-3.New perspective on mTOR pathways: a new target of depression -- 2-4.Cellular aging in depression: the role of telomere-telomerase system -- 2-5.Differentiation and biological markers in subtype of depression -- 3.Neural circuit-level aspect of depression -- 3-1.Molecular, structural, and functional neuroimaging in depression -- 3-2.Resting-state activity in depression; a link to spatiotemporal psychopathology -- 3-3.Functional neuroimaging in depression: a tool to predict treatment outcome and response -- 3-4.Cortical-subcortical interactions in the pathophysiology of depression -- 3-5.Pathophysiology and treatment strategies for different types of depression -- 3-6.The effect of neurostimulation in depression -- 4.Multicellular system-level aspect of depression -- 4-1.Inflammation, depression and neurodegeneration: a possible cause of dementia in late life depression? -- 4-2.Gut-microbiota-brain axis and depression -- 4-3.The interactions of immune inflammation and oxidative and nitrosative stress with the kynurenine and melatonergic pathways in depression -- 4-4.Glia-neuron cross-talk in depression -- 4-5.Depression model in primate: relevance to novel drug discovery -- 5.Species-, individual-, gender-, culture-specific aspects of depression -- 5-1.Precision psychiatry: personalized clinical approach to depression -- 5-2.Gender differences in depression -- 5-3.An up-date on the epidemiology of major depressive disorder across cultures.
520 $a This book, in two volumes, focuses on contemporary issues and dilemmas in relation to depression. The aim is to equip readers with an up-to-date understanding of the clinical and neurobiological underpinnings of depression and their relation to clinical manifestations and the development of more effective treatments. This first volume is devoted specifically to biomedical and neurobiological issues. Detailed information is presented on a wide range of topics, including genetics, molecular and cellular biology, and aspects at the neural circuit and multicellular system levels. Readers will gain a deeper appreciation of the factors and interactions underlying individual variation in responsiveness to stress and vulnerability to depression, as well as a clear understanding of potential treatment targets and causes of treatment resistance based on the latest research. A concluding section considers progress towards precision psychiatry and gender and cultural differences in depression. The companion volume is dedicated to clinical and management issues in depression. Understanding Depression will be an excellent source of information for both researchers and practitioners in the field.
650 0 $a Psychiatry. $3 585488
650 0 $a Neurology . $3 1253459
650 0 $a Neurosciences. $3 593561
650 0 $a Molecular biology. $3 583443
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Medical biochemistry. $3 1254555
650 2 4 $a Neurology. $3 593894
650 2 4 $a Molecular Medicine. $3 668353
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Medical Biochemistry. $3 668897
700 1 $a Kim, Yong-Ku. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1284669
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811065798
776 0 8 $i Printed edition: $z 9789811065811
776 0 8 $i Printed edition: $z 9789811349072
856 4 0 $u https://doi.org/10.1007/978-981-10-6580-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)